Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suman Kumar Ray

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Recent Advances in Anti-Infective Drug Discovery|November 25, 2021
The Newfangled Upsurge of Double Mutant SARS-CoV-2 Virus in 2021-Current Scenario and Inspecting AheadSukhes Mukherjee, Suman Kumar Ray
Current Molecular Medicine|December 23, 2021
Starring Role of Biomarkers and Anticancer Agents as a Major Driver in Precision Medicine of Cancer TherapySuman Kumar Ray, Sukhes Mukherjee
Recent Advances in Anti-Infective Drug Discovery|November 23, 2021
The Spectrum of Biochemical Alterations with Molecular and Serological Biomarkers in the Diagnosis of COVID-19: Searching for Novel One to Identify Disease Earlier with Better Prognosis and Drug DiscoverySuman Kumar Ray, Sukhes Mukherjee
Anti-Cancer Agents in Medicinal Chemistry|July 13, 2021
Consequences of Extracellular Matrix Remodeling in Headway and Metastasis of Cancer along with Novel Immunotherapies: A Great Promise for Future EndeavorSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|April 3, 2022
A New Wave of COVID-19 in 2021 with Unique Genetic Characters - Present Global Scenario and Beholding OnwardsSukhes Mukherjee, Suman Kumar Ray
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2024
Breast cancer stem cells as novel biomarkersSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|January 23, 2024
A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from OverSuman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|May 20, 2024
Limning of HIF-2 and HIF-3 in the Tumor Microenvironment: Developing Concepts for the Treatment of Hypoxic CancerSuman Kumar Ray, Sukhes Mukherjee
Free Radical Research|January 28, 2021
Molecular and biochemical investigations of inborn errors of metabolism-altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuriaSuman Kumar Ray, Sukhes Mukherjee
Current Drug Targets|January 13, 2022
Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug TargetsSuman Kumar Ray, Sukhes Mukherjee
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Recent Advances in Anti-Infective Drug Discovery|November 25, 2021
The Newfangled Upsurge of Double Mutant SARS-CoV-2 Virus in 2021-Current Scenario and Inspecting AheadSukhes Mukherjee, Suman Kumar Ray
Current Molecular Medicine|December 23, 2021
Starring Role of Biomarkers and Anticancer Agents as a Major Driver in Precision Medicine of Cancer TherapySuman Kumar Ray, Sukhes Mukherjee
Recent Advances in Anti-Infective Drug Discovery|November 23, 2021
The Spectrum of Biochemical Alterations with Molecular and Serological Biomarkers in the Diagnosis of COVID-19: Searching for Novel One to Identify Disease Earlier with Better Prognosis and Drug DiscoverySuman Kumar Ray, Sukhes Mukherjee
Anti-Cancer Agents in Medicinal Chemistry|July 13, 2021
Consequences of Extracellular Matrix Remodeling in Headway and Metastasis of Cancer along with Novel Immunotherapies: A Great Promise for Future EndeavorSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|April 3, 2022
A New Wave of COVID-19 in 2021 with Unique Genetic Characters - Present Global Scenario and Beholding OnwardsSukhes Mukherjee, Suman Kumar Ray
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2024
Breast cancer stem cells as novel biomarkersSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|January 23, 2024
A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from OverSuman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|May 20, 2024
Limning of HIF-2 and HIF-3 in the Tumor Microenvironment: Developing Concepts for the Treatment of Hypoxic CancerSuman Kumar Ray, Sukhes Mukherjee
Free Radical Research|January 28, 2021
Molecular and biochemical investigations of inborn errors of metabolism-altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuriaSuman Kumar Ray, Sukhes Mukherjee
Current Drug Targets|January 13, 2022
Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug TargetsSuman Kumar Ray, Sukhes Mukherjee
Pageof 8